23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-119.29%
Negative revenue growth while Insurance - Life median is -4.49%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-119.29%
Negative gross profit growth while Insurance - Life median is -15.50%. Seth Klarman would suspect poor product pricing or inefficient production.
46.26%
EBIT growth exceeding 1.5x Insurance - Life median of 7.09%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
46.26%
Operating income growth exceeding 1.5x Insurance - Life median of 7.09%. Joel Greenblatt would see if unique processes drive exceptional profitability.
42.69%
Net income growth exceeding 1.5x Insurance - Life median of 3.71%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
41.51%
EPS growth of 41.51% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
42.71%
Diluted EPS growth of 42.71% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
0.84%
Slight dilution while Insurance - Life median is negative. Peter Lynch might worry the firm is missing an opportunity to reduce shares like peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.52%
Negative OCF growth while Insurance - Life median is -51.94%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-62.52%
Negative FCF growth while Insurance - Life median is -56.51%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-205.76%
Negative 10Y revenue/share CAGR while Insurance - Life median is 16.36%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
-130.68%
Negative 5Y CAGR while Insurance - Life median is 12.45%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-117.44%
Negative 3Y CAGR while Insurance - Life median is 5.50%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
-5.33%
Negative 10Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-21.38%
Negative 5Y OCF/share CAGR while Insurance - Life median is -11.45%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-35.98%
Negative 3Y OCF/share CAGR while Insurance - Life median is -5.62%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
136.89%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 56.82% over a decade. Joel Greenblatt might see a standout compounder of earnings.
113.68%
5Y net income/share CAGR > 1.5x Insurance - Life median of 27.02%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
32.14%
Positive 3Y CAGR while Insurance - Life median is negative. Peter Lynch sees a big short-term advantage vs. peers struggling with profit declines.
117.57%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 60.05% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
26.75%
5Y equity/share CAGR 75-90% of Insurance - Life median. John Neff calls for higher returns or more efficient buybacks to match peers.
14.09%
3Y equity/share CAGR 75-90% of Insurance - Life median. John Neff calls for overhead or margin tweaks to keep pace with peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.46%
AR growth of 0.46% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
-5.72%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-4.24%
Negative BV/share change while Insurance - Life median is -7.75%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
7.01%
Slightly rising debt while Insurance - Life median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
No Data
No Data available this quarter, please select a different quarter.
-5.10%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.